SG11202111538PA - Alternative process for the preparation of 4-phenyl-5-alkoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]-3-oxo-5,6,8,8a-tetrahydro-1h-imidazo[1,5-a]pyrazin-2-yl]-carboxylic acid - Google Patents

Alternative process for the preparation of 4-phenyl-5-alkoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]-3-oxo-5,6,8,8a-tetrahydro-1h-imidazo[1,5-a]pyrazin-2-yl]-carboxylic acid

Info

Publication number
SG11202111538PA
SG11202111538PA SG11202111538PA SG11202111538PA SG11202111538PA SG 11202111538P A SG11202111538P A SG 11202111538PA SG 11202111538P A SG11202111538P A SG 11202111538PA SG 11202111538P A SG11202111538P A SG 11202111538PA SG 11202111538P A SG11202111538P A SG 11202111538PA
Authority
SG
Singapore
Prior art keywords
dihydropyrimidin
pyrazin
thiazol
imidazo
alkoxycarbonyl
Prior art date
Application number
SG11202111538PA
Inventor
Daniel Vincent Fishlock
Jianshu Liu
Paul Spurr
Georg Wuitschik
Zhixiang Xu
Fugui Zhang
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SG11202111538PA publication Critical patent/SG11202111538PA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SG11202111538PA 2019-06-06 2020-06-04 Alternative process for the preparation of 4-phenyl-5-alkoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]-3-oxo-5,6,8,8a-tetrahydro-1h-imidazo[1,5-a]pyrazin-2-yl]-carboxylic acid SG11202111538PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2019090358 2019-06-06
PCT/EP2020/065424 WO2020245246A1 (en) 2019-06-06 2020-06-04 Alternative process for the preparation of 4-phenyl-5-alkoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]-3-oxo-5,6,8,8a-tetrahydro-1h-imidazo[1,5-a]pyrazin-2-yl]-carboxylic acid

Publications (1)

Publication Number Publication Date
SG11202111538PA true SG11202111538PA (en) 2021-11-29

Family

ID=71069823

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202111538PA SG11202111538PA (en) 2019-06-06 2020-06-04 Alternative process for the preparation of 4-phenyl-5-alkoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]-3-oxo-5,6,8,8a-tetrahydro-1h-imidazo[1,5-a]pyrazin-2-yl]-carboxylic acid

Country Status (14)

Country Link
US (1) US20220315588A1 (en)
EP (1) EP3980419A1 (en)
JP (1) JP2022535112A (en)
KR (1) KR20220018486A (en)
CN (1) CN114026095A (en)
AR (1) AR119098A1 (en)
AU (1) AU2020288329A1 (en)
BR (1) BR112021024398A2 (en)
CA (1) CA3142659A1 (en)
IL (1) IL288585A (en)
MX (1) MX2021014850A (en)
SG (1) SG11202111538PA (en)
TW (1) TW202112781A (en)
WO (1) WO2020245246A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020249331A1 (en) 2019-03-25 2021-09-23 F. Hoffmann-La Roche Ag Solid forms of a compound of HBV core protein allosteric modifier

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100348588C (en) * 2005-12-02 2007-11-14 浙江工业大学 Chemical synthesis method of pyrimidine thioketone
SG11201607332UA (en) 2014-03-07 2016-10-28 Hoffmann La Roche Novel 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
WO2017064156A1 (en) * 2015-10-16 2017-04-20 F. Hoffmann-La Roche Ag Novel 6-fused and 2-heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
AR107633A1 (en) 2016-02-19 2018-05-16 Hoffmann La Roche PROCEDURE FOR THE PREPARATION OF ACID 4-PHENYL-5-ALCOXICARBONIL-2-TIAZOL-2-IL-1,4-DIHYDROPIRIMIDIN-6-IL- [METHYL] -3-OXO-5,6,8,8A-TETRAHIDRO- 1H-IMIDAZO [1,5A] PIRAZIN-2-IL-CARBOXYL
CN109153682B (en) * 2016-05-20 2021-05-25 豪夫迈·罗氏有限公司 Novel pyrazine compounds with oxygen, sulfur and nitrogen linkers for the treatment of infectious diseases
JP2021008404A (en) * 2017-09-27 2021-01-28 アスタファーマシューティカルズ株式会社 Osteoarthritis improving agent
KR102667040B1 (en) * 2017-10-18 2024-05-20 선샤인 레이크 파르마 컴퍼니 리미티드 Dihydropyrimidine compounds and their use in medicine

Also Published As

Publication number Publication date
AU2020288329A1 (en) 2021-11-18
CN114026095A (en) 2022-02-08
BR112021024398A2 (en) 2022-01-18
JP2022535112A (en) 2022-08-04
KR20220018486A (en) 2022-02-15
US20220315588A1 (en) 2022-10-06
CA3142659A1 (en) 2020-12-10
AR119098A1 (en) 2021-11-24
MX2021014850A (en) 2022-01-18
WO2020245246A1 (en) 2020-12-10
EP3980419A1 (en) 2022-04-13
TW202112781A (en) 2021-04-01
IL288585A (en) 2022-02-01

Similar Documents

Publication Publication Date Title
IL286912A (en) Process for the preparation of 4-phenyl-5-alkoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]-3-oxo-5,6,8,8a-tetrahydro-1h-imidazo[1,5-a]pyrazin-2-yl]-carboxylic acid
IL266170A (en) Process for the preparation of pyrazolo[1,5-a]pyrimidines and salts thereof
MX2020003458A (en) Radiolabelled derivatives of a 2-amino-6-fluoro-n-[5-fluoro-pyrid in-3-yl]- pyrazolo[1,5-a]pyrimidin-3-carboxamide compound useful as atr kinase inhibitor, the preparation of said compound and different solid forms thereof.
MX2021011438A (en) Imidazopyrrolopyridine as inhibitors of the jak family of kinases.
SG10201804791UA (en) 2-amino-6-fluoro-n-[5-fluoro-pyridin-3-yl]pyrazolo[1,5-a]pyrimidin-3-carboxamide compound useful as atr kinase inhibitor, its preparation, different solid forms and radiolabelled derivatives thereof
MX2019007073A (en) Small molecule inhibitors of the jak family of kinases.
WO2013077921A3 (en) Substituted pyrazolo[3,4-d]pyrimidines and uses thereof
IL283149A (en) 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-one derivatives as hpk1 inhibitors for the treatment of cancer
IL267801A (en) Process for the preparation of 3-substituted 5-amino-6h-thiazolo[4,5-d]pyrimidine-2,7-dione compounds
IL286870A (en) Hexahydro-1h-pyrazino[1,2-a]pyrazine compounds for the treatment of autoimmune disease
EP3551630A4 (en) IMIDAZO [1,5-A]PYRAZINE DERIVATIVES AS PI3Kdelta INHIBITORS
IL272988A (en) Imidazo[1,5-a]pyrazine derivatives as pi3kdelta inhibitors
IL288585A (en) Alternative process for the preparation of 4-phenyl-5-alkoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]-3-oxo-5,6,8,8a-tetrahydro-1h-imidazo[1,5-a]pyrazin-2-yl]-carboxylic acid
EP3668822A4 (en) Process for preparing improved 3,4-dimethyl-1h-pyrazole phosphate formulations
IL285550A (en) Process for the preparation of polyamides
EP3813532A4 (en) Process for the preparation of quinmerac
AU2018297073A1 (en) Process for the preparation of morphinane compounds
EP4069693C0 (en) Hydropyrido[1,2-alpha]pyrazine compounds for the treatment of autoimmune diseases
CA3052361A1 (en) Process for the preparation of benzodiazepine derivatives
EP3814364A4 (en) Improved process for preparation of 2,3,4,6-tetra-o-benzyl-d-galactose
EP3845231A4 (en) Therapeutic agent containing pyrazolo[3,4-d]pyrimidine compound as active ingredient
HK1257427A1 (en) A process for the preparation of 2-pyrazolo[1,5-a]pyrazin-2-ylpyrido[1,2-a]pyrimidin-4-one